FDA

Jun 22, 2021

Horizon/ Arrowhead Deal; Dr Reddy’s Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill’s Oral Opaganib in COVID-19

Jun 16, 2020

HCQ/ CQ failure; AZ/ Catalent’s deal; Sinovac’s CoronaVac and Lilly’s Olumiant trial results

Oct 29, 2019

AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use to prevent pregnancy; Gilead, Glympse Bio teams up to advance NASH clinical development

Oct 22, 2019

FDA approval to AZ’s Farxiga for heart failure; GSK divests two travel vaccines to Bavarian Nordic; New breakthrough therapy for Cystic Fibrosis

Oct 10, 2019

First oral GLP-1 treatment approved for type2 Diabetes

Oct 04, 2019

FDA is reviewing a dangerous way to treat Peanut Allergy

Sep 20, 2019

Roche’s Gazyva receives FDA Breakthrough designation for Lupus nephritis

Sep 18, 2019

FDA approves Ibsrela to reduce the global burden of Irritable Bowel Syndrome

Sep 10, 2019

Daiichi Sankyo fuels commercialization of DS-8201 in Japan; Roivant Sciences transfers its biotech stake for USD 3 Billion; FDA, EMA accepts marketing of Allergan’s abicipar

Sep 09, 2019

FDA approves Ofev for interstitial lung disease

Newsletter/Whitepaper